Ping An

2.9k total citations · 1 hit paper
64 papers, 1.4k citations indexed

About

Ping An is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Ping An has authored 64 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Oncology and 13 papers in Genetics. Recurrent topics in Ping An's work include Inflammatory Bowel Disease (11 papers), Gastric Cancer Management and Outcomes (7 papers) and Microscopic Colitis (6 papers). Ping An is often cited by papers focused on Inflammatory Bowel Disease (11 papers), Gastric Cancer Management and Outcomes (7 papers) and Microscopic Colitis (6 papers). Ping An collaborates with scholars based in China, United States and South Korea. Ping An's co-authors include Yury Popov, Kahini A. Vaid, Shuangshuang Zhao, Makoto Miyamoto, Kaori Kuramitsu, Linlin Wei, Michelle Lai, Deanna Sverdlov, Hesheng Luo and Xiaoying Liu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Molecular Cell.

In The Last Decade

Ping An

60 papers receiving 1.4k citations

Hit Papers

Hepatocyte mitochondria-derived danger signals directly a... 2020 2026 2022 2024 2020 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ping An China 21 548 349 303 217 181 64 1.4k
Shinya Sato Japan 23 536 1.0× 410 1.2× 195 0.6× 238 1.1× 305 1.7× 102 1.9k
Yasuyuki Okamoto Japan 22 532 1.0× 300 0.9× 189 0.6× 246 1.1× 152 0.8× 118 1.5k
Bin Xie China 20 600 1.1× 157 0.4× 211 0.7× 175 0.8× 98 0.5× 46 1.3k
Wenting Liu China 18 512 0.9× 231 0.7× 212 0.7× 109 0.5× 145 0.8× 58 1.3k
Yuki Niwa Japan 20 493 0.9× 301 0.9× 157 0.5× 182 0.8× 465 2.6× 58 1.3k
Sonja Djudjaj Germany 28 941 1.7× 230 0.7× 163 0.5× 238 1.1× 132 0.7× 51 2.2k
Noriyuki Koyama Japan 24 821 1.5× 237 0.7× 346 1.1× 350 1.6× 131 0.7× 64 2.1k
Feixiang Wu China 24 551 1.0× 359 1.0× 290 1.0× 246 1.1× 494 2.7× 48 1.5k
James E. Esplen United States 11 945 1.7× 186 0.5× 392 1.3× 139 0.6× 197 1.1× 11 1.7k
Efstathios Antoniou Greece 20 422 0.8× 119 0.3× 515 1.7× 356 1.6× 262 1.4× 83 1.4k

Countries citing papers authored by Ping An

Since Specialization
Citations

This map shows the geographic impact of Ping An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping An more than expected).

Fields of papers citing papers by Ping An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping An. The network helps show where Ping An may publish in the future.

Co-authorship network of co-authors of Ping An

This figure shows the co-authorship network connecting the top 25 collaborators of Ping An. A scholar is included among the top collaborators of Ping An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping An. Ping An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Weijun, Liang Yue, Hongjie Jiang, et al.. (2025). Proteomic profiling in cerebrospinal fluid reveal biomarkers for shunt outcome in idiopathic normal-pressure hydrocephalus. Journal of Advanced Research. 80. 671–682.
2.
Tian, Shan, Jixiang Zhang, Ping An, et al.. (2024). Comprehensive analysis of psychological symptoms and quality of life in early patients with IBD: a multicenter study from China. BMC Psychiatry. 24(1). 792–792. 1 indexed citations
3.
Peng, Zhenwei, Guangyan Wei, Pinzhu Huang, et al.. (2024). ASK1/p38 axis inhibition blocks the release of mitochondrial “danger signals” from hepatocytes and suppresses progression to cirrhosis and liver cancer. Hepatology. 80(2). 346–362. 7 indexed citations
4.
Liu, Chuan, Jixiang Zhang, Fei Liao, et al.. (2024). Evaluating Inflammatory Bowel Disease-Related Quality of Life Using an Interpretable Machine Learning Approach: A Multicenter Study in China. Journal of Inflammation Research. Volume 17. 5271–5283. 2 indexed citations
5.
Li, Zhaoyang, Ziying Wang, Hang Zhang, et al.. (2024). P53 upregulation by USP7-engaging molecular glues. Science Bulletin. 69(12). 1936–1953. 5 indexed citations
6.
Kang, Jian, Jing Wang, Juan Su, et al.. (2023). Efficacy of Ustekinumab Optimization by 2 Initial Intravenous Doses in Adult Patients With Severe Crohn’s Disease. Inflammatory Bowel Diseases. 30(8). 1295–1302. 5 indexed citations
7.
Liu, Chuan, Jixiang Zhang, Ping An, et al.. (2023). Risk factors for poor sleep quality in patients with inflammatory bowel disease in China: A multicenter study. Frontiers in Psychiatry. 14. 1130396–1130396. 1 indexed citations
8.
Kang, Jian, et al.. (2023). P677 Combination of vedolizumab and exclusive enteral nutrition in patients with moderate to severe Crohn’s Disease. Journal of Crohn s and Colitis. 17(Supplement_1). i808–i810.
9.
An, Ping, Linlin Wei, Shuangshuang Zhao, et al.. (2020). Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis. Nature Communications. 11(1). 2362–2362. 228 indexed citations breakdown →
10.
Wei, Guangyan, Jingsong Cao, Pinzhu Huang, et al.. (2020). Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4 mouse model of PFIC3. Journal of Hepatology. 74(6). 1416–1428. 48 indexed citations
11.
An, Ping, Guangyan Wei, Pinzhu Huang, et al.. (2020). A novel non‐bile acid FXR agonist EDP‐305 potently suppresses liver injury and fibrosis without worsening of ductular reaction. Liver International. 40(7). 1655–1669. 45 indexed citations
12.
Guo, Yuanmei, Jixiang Zhang, Qiutang Xiong, et al.. (2020). Clinical characteristics of 70 patients with coronavirus disease 2019 accompanied with diarrhea. Zhonghua xiaohua zazhi. 40. 1 indexed citations
13.
Wei, Guangyan, Ping An, Kahini A. Vaid, et al.. (2019). Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer. American Journal of Physiology-Gastrointestinal and Liver Physiology. 318(1). G174–G188. 57 indexed citations
15.
Kang, Kyung A., et al.. (2013). Primo Vascular System and Its Potential Role in Cancer Metastasis. Advances in experimental medicine and biology. 789. 289–296. 20 indexed citations
16.
Liu, Yaling, Yu Zhou, Xiao Feng, et al.. (2013). MicroRNA-126 functions as a tumor suppressor in colorectal cancer cells by targeting CXCR4 via the AKT and ERK1/2 signaling pathways. International Journal of Oncology. 44(1). 203–210. 59 indexed citations
17.
Zhang, Limin, Ping An, Chao Jiang, et al.. (2012). Propofol Increases Expression of Basic Fibroblast Growth Factor After Transient Cerebral Ischemia in Rats. Neurochemical Research. 38(3). 530–537. 17 indexed citations
18.
An, Ping, Jingxing Dai, Zhendong Su, et al.. (2010). Putative Primo-vascular System in Mesentery of Rats. Journal of Acupuncture and Meridian Studies. 3(4). 232–240. 9 indexed citations
19.
An, Ping. (2007). KN-93, a specific inhibitor of CaMKII inhibits human hepatic stellate cell proliferation бin vitro��. World Journal of Gastroenterology. 13(9). 1445–1445. 13 indexed citations
20.
An, Ping, et al.. (2005). Bradykinin preconditioning induces protective effects against focal cerebral ischemia in rats. Brain Research. 1059(2). 105–112. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026